Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases.

Sun Z, Sood S, Li N, Yang P, Newman RA, Yang CS, Chen X. Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases. Oral Oncol. 2008 Jul; 44(7):652-7.

View in: PubMed

subject areas

9,10-Dimethyl-1,2-benzanthracene
Animals
Arachidonate 5-Lipoxygenase
Carcinogens
Carcinoma, Squamous Cell
Cell Transformation, Neoplastic
Cheek
Cricetinae
Dinoprostone
Humans
Male
Mouth Mucosa
Mouth Neoplasms
Quinazolines
Receptor, erbB-2

authors with profiles

Luke Chen

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support